Skip to main content
Premium Trial:

Request an Annual Quote

The Next Stage

The Boston-based Partners HealthCare System plans to implement whole-genome sequencing and interpretation of that data for its hospitals next month, The Boston Globe reports. Its nine hospitals include Massachusetts General Hospital and Brigham and Women's Hospital. The Globe adds that the service is expected to cost about $9,000.

Prior to launching the service, the hospital system has partnered with Illumina to include its GeneInsight software, which was developed in part to help with data interpretation, with Illumina's MiSeq machine. Currently, the Globe adds, that software-machine combo is being used in a few pilot projects for targeted gene testing.

"As an academic medical center, we can differentiate ourselves around interpreting genetic data," says Trung Do, executive director of business development at Partners.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.